Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug D

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

Related Keywords

United States , Canada , Ottawa , Ontario , , Tetra Bio Pharma Inc , European Commission , Committee For Orphan Medicinal Products , European Union , European Medicines Agency , Health Canada , Regulation Services Provider , Orphan Medicinal Products , Orphan Drug Designation , Complex Regional Pain Syndrome , Guy Chamberland , Chief Executive Officer , Chief Regulatory Officer , Tetra Bio Pharma , Scientific Advice , Regional Pain Syndrome , Biotechnology , Pharmaceuticals , Health Care Amp Hospitals , Medical Pharmaceuticals , Otc , Mallcap , Cannabis , Clinical Trials Amp Medical Discoveries ,